GGrantIndex
Sort

10,829 grants matching car t

Flow Cytometry Shared Service

$1
Xiaoxuan Fan · University Of Maryland Baltimore · P30 · FY2021 · CA

Cell Therapies Core

$1
Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2023 · CA

Development and Validation of a Patient-Reported Measure Assessing Chimeric Antigen Receptor (CAR) T-Cell Therapy-Related Side Effects

$1
Anna Barata · H. Lee Moffitt Cancer Ctr & Res Inst · R03 · FY2022 · CA

Blood-to-CNS Drug Uptake in Pain

$1
Thomas Paul Davis · University Of Arizona · R01 · FY2012 · DA

Cellular Control: Synthetic Signaling/Motility (RMI)

$1
Wendell A Lim · University Of California, San Francisco · PN2 · FY2014 · EY

Small Animal Imaging Facility

$1
Edward J Delikatny · University Of Pennsylvania · P30 · FY2023 · CA

Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis

$1
David Schnadower · Washington University · R01 · FY2018 · HD

A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma

$1
Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Minimally invasive access and aspiration of circulating lymphocytes from the thoracic duct

$1
Matthew Callaghan · Lxs, Inc. · SB1 · FY2023 · DK

Technological Innovations for Live Kidney Donor Follow-up Care Management

$1
Macey Leigh Levan · Johns Hopkins University · K01 · FY2021 · DK

Mobile Ecological Momentary Diet Assessment: A Low Burden, Ecologically-Valid Approach to Measuring Dietary Intake in Near-Real Time

$1
Susan Schembre · University Of Arizona · R01 · FY2022 · CA

mHealth to address diabetes control among homeless adults

$1
Ramin Asgary · George Washington University · R21 · FY2022 · MD

Metabolomics Shared Resource

$1
Daniel Patrick Kelly · University Of Pennsylvania · P30 · FY2023 · CA

Cellular Control: Synthetic Signaling/Motility (RMI)

$1
Wendell A Lim · University Of California, San Francisco · PN2 · FY2012 · EY

Inflammation, Microbiota and Cancer

$1
Thale Cross Jarvis · Keystone Symposia · R13 · FY2020 · CA

Flow Cytometry Shared Service

$1
Xiaoxuan Fan · University Of Maryland Baltimore · P30 · FY2024 · CA

Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)

$1
Flavio Vincenti · University Of California, San Francisco · U01 · FY2021 · AI

Metabolic reprogramming to improve EGFRvIII CAR T cell persistence

$1
John H Sampson · Duke University · R21 · FY2022 · CA

Developmental flame retardant exposure, gut microbiome, and obesity

$1
Julia Yue Cui · University Of Washington · R01 · FY2025 · ES

Shared Research Project

$1
Vikram H Patel · London Sch/Hygiene & Tropical Medicine · U19 · FY2012 · MH

Flow Cytometry Shared Service

$1
Xiaoxuan Fan · University Of Maryland Baltimore · P30 · FY2022 · CA

Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM

$1
Loic Pierre Deleyrolle · University Of Florida · R21 · FY2024 · CA

Cellular Control: Synthetic Signaling/Motility (RMI)

$1
Wendell A Lim · University Of California, San Francisco · PN2 · FY2013 · EY

Development of novel cell and gene therapies

$0
David Stroncek · Clinical Center · ZIA · FY2016 · CL

Big Data - Epidemiology of Critical Illness and Sepsis

$0
Sameer Kadri · Clinical Center · ZIA · FY2021 · CL